Mabry Medical

Retatrutide has sparked hope — and important safety questions. Our latest blog explains why this research-grade compound is not FDA-approved, the risks of using investigational products outside clinical trials, and how patients can make informed choices about metabolic and weight-loss therapies. Read more: https://wix.to/5wObfiD

The Promise and Caution of Retatrutide: Understanding Research-Grade Medications for Patients Retatrutide has drawn attention for promising early results in weight-loss and metabolic research. However, it is a research-grade, non-FDA-approved compound and is not intended for routine clinical use. Products marketed outside of clinical trials may carry safety, quality, and regulatory risks. Pa...

Light ci******es didn’t make smoking safer—they made to***co companies richer. In our latest post, Dr. Bryan Mabry MD exposes how misleading labels and engineered filters perpetuated the “light” myth and its real harms. Read the full breakdown and learn what to watch for next time you see labels promising reduced risk. https://wix.to/Aq0DQAJ

Unveiling the Truth Behind the Light Cigarette Scam Light ci******es didn’t make smoking safer—they made the industry more profitable. Learn how misleading labels and engineered filters shaped one of to***co’s most damaging myths.